Human Vaccine Market by RoA and Geography - Forecast and Analysis 2021-2025

  • Published: Mar 2021
  • Pages: 120
  • SKU: IRTNTR70325

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The human vaccine market size has the potential to grow by USD 18.52 billion during 2021-2025, and the market’s growth momentum will decelerate at a CAGR of 6.90%. 

This report provides a detailed analysis of the market by RoA (intramuscular, subcutaneous, oral, and others), geography (North America, Europe, Asia, and ROW), and key vendors. 

Market Overview


Browse TOC and LoE with selected illustrations and example pages of Human Vaccine Market

 Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 


  • Bavarian Nordic AS
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.


The human vaccine market is fragmented and the vendors are deploying growth strategies such as strategic alliances to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as the need for novel vaccines for chronic infections to achieve growth opportunities. However, factors such as the need for annual reformulations of vaccines to match circulating strains will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the human vaccine market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This human vaccine market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. 

Human Vaccine Market: Key Drivers and Trends

  • The increase in investments in vaccine segment will fuel the growth of the human vaccine market size.
  • High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.
  • Companies across the world are increasingly investing in new vaccine development.
  • In November 2020, CEPI received a grant of up to $20 million from the Bill & Melinda Gates Foundation to expand its portfolio of COVID-19 vaccines to include candidates that are different from those already in the advanced development stage.
  • In December 2020, China's Sinovac Biotech announced that it had secured approximately $500 million in funding for the development of its COVID-19 vaccine. 
  • The need for novel vaccines for chronic infections is one of the significant factors driving human vaccine market growth.
  • The need for novel vaccines to prevent several emerging and re-emerging infectious diseases is increasing.
  • Government and non-government organizations worldwide are increasing the research on novel vaccines for various infections, including HIV, Staphylococcus aureus, C. difficile, influenza, and respiratory syncytial virus.
  • With the use of new and traditional technologies, many vaccine candidates have been studied in clinical research.
  • Globally, there are numerous vaccine targets, including Group A streptococcal meningitis, Chlamydia trachomatis, pneumococcal, universal influenza, and C. difficile. 


Grab your Free Sample now to unlock further information on other key market drivers

Human Vaccine Market: Segmentation by Geography


For more insights on the market share of various regions Request for a FREE sample now!

41% of the market’s growth will originate from North America during the forecast period. The US is a key market for human vaccines in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.

To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

Human Vaccine Market: Segmentation by RoA


Request for a FREE sample and Get more information on the market contribution of various segments

The intramuscular segment is expected to witness accelerated growth during the forecast period. One of the main reasons for this growth is the benefits of intramuscular administration. It is efficient and safe in inducing an immune response compared with the oral ROA. The market has witnessed the development and approval of an intramuscular vaccine for COVID-19, which is expected to drive the growth of the segment during the forecast period. 

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the human vaccine market size.



Request for a FREE sample

Human Vaccine Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive human vaccine market growth during the next five years
  • Precise estimation of the human vaccine market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the human vaccine industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of human vaccine market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Human Vaccine Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Decelerate at a CAGR of 7%

Market growth 2021-2025

$ 18.52 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 41%

Key consumer countries

US, Germany, UK, France, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Bavarian Nordic AS, CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, and Serum Institute of India Pvt. Ltd.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The human vaccine market growth will increase by $18.52 billion during 2020-2025.
The human vaccine market is expected to grow at a CAGR of 6.90% during 2020-2025.
Technavio has segmented the human vaccine market by other1 (Intramuscular, Subcutaneous, Oral, and Others) and geographic (North America, Europe, Asia, and ROW).
Bavarian Nordic AS, CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd. are a few of the key vendors in the human vaccine market.
North America will register the highest growth rate of 40.98% among the other regions. Therefore, the human vaccine market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the human vaccine market growth are:
  • Increase in investments in vaccines segment
  • Varied demand for vaccines in high-income and developing countries
The human vaccine market vendors should focus on grabbing business opportunities from the intramuscular segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>